Now showing items 1-2 of 2

    • Artigo 

      Are There Cochlear Dead Regions Involved in Hearing Loss after Cisplatin Ototoxicity? 

      Schultz, Christiane; Liberman, Patricia Helena Pecora; Goffi-Gomez, Maria Valéria Schmidt (Audiol Neurootol. 2019;24(5):253-257. doi: 10.1159/000502250., 2019-11)
      BACKGROUND: The most common complaint of patients affected by chemotherapy-induced hearing loss is difficulty understanding speech in noisy environments despite the use of hearing aids. Cochlear dead regions, those areas ...
    • Artigo 

      Contribution of the GSTP1 c.313A>G variant to hearing loss risk in patients exposed to platin chemotherapy during childhood. 

      Liberman, Patricia Helena Pecora; Goffi-Gomez, Maria Valéria Schmidt; Schultz, Christiane; Jacob, P. L.; Paula, C. A. A. de; Sartorato, E. L.; Torrezan, G. T.; Ferreira, E. N; Carraro, D. M. (Clin Transl Oncol. 2019 May;21(5):630-635. doi: 10.1007/s12094-018-1964-7., 2019-05)
      BACKGROUND AND AIM: Ototoxicity is a potential adverse effect of chemotherapy with platin drugs, such as cisplatin and carboplatin, in children. Hearing loss (HL) affecting frequencies below 4 kHz can compromise speech ...